Cardio Diagnostics shares surge 19.46% premarket after announcing partnerships with Southdale YMCA and India's Dr. Lal PathLabs to expand heart health services and diagnostics.

Cardio Diagnostics (CDIO) surged 19.46% in premarket trading following the announcement of two strategic partnerships expanding its market reach. The company partnered with Southdale YMCA to enhance cardiovascular education and testing in Minnesota, targeting 14,000 community members, and with Aimil Ltd. and Dr. Lal PathLabs to launch its PrecisionCHD™ test in India, marking its first international expansion. These moves underscore Cardio Diagnostics’ growth strategy, leveraging partnerships to broaden access to its AI-powered diagnostics in both domestic and emerging markets. The partnerships address growing cardiovascular disease prevalence in the U.S. and India, positioning the company to capitalize on demand for advanced, accessible testing solutions.